46 results on '"Chen, Pei-Jer"'
Search Results
2. Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals
3. Factors associated with pre-treatment hyperferritinemia in patients with chronic hepatitis C virus infection
4. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
5. Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level
6. Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus
7. Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
8. Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes
9. Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
10. Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
11. The origin and underlying driving forces of the SARS-CoV-2 outbreak
12. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)
13. HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
14. Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection
15. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
16. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
17. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model
18. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
19. Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
20. Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
21. Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
22. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission
23. Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B
24. Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan
25. Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
26. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
27. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions
28. Dual chronic hepatitis B virus and hepatitis C virus infection
29. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
30. A micro circulating PCR chip using a suction-type membrane for fluidic transport
31. Metabolic profiles in patients with chronic hepatitis C: a case–control study
32. Genetic structural differences between responders and non-responders to interferon therapy for chronic hepatitis-B patients
33. Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
34. Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells
35. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B
36. Ribavirin enhances interferon-γ levels in patients with chronic hepatitis C treated with interferon-α
37. Long-term culture of hepatocytes from human adults
38. Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C
39. Hepatocyte growth factor stimulates the growth and activates mitogen-activated protein kinase in human hepatoma cells
40. Inhibition of hepatitis delta virus genomic ribozyme self-cleavage by aminoglycosides
41. Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: Correlation with genotypes
42. Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay: A clinicopathologic study and demonstration of the usefulness of a third-generation assay
43. Detection of divergent hepatitis C virus envelope sequences
44. Characterization of T cell clones specific to a determinant of hepatitis B virus core and e antigens in chronic type B hepatitis: Implication for a T cell mechanism of HBV immunopathogenesis
45. Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications
46. Hepatitis C virus infection in Taiwan
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.